Bernson, E
Hallner, A
Sander, F E
Wilsson, O
Werlenius, O
Rydström, A
Kiffin, R
Brune, M
Foà, R
Aurelius, J
Martner, A
Hellstrand, K
Thorén, F B
Article History
Received: 1 March 2017
Revised: 3 May 2017
Accepted: 9 May 2017
First Online: 22 May 2017
Competing interests
: Authors MB and KH are past or present consultants to the study sponsor (Meda Pharma). Author KH holds patents protecting the use of histamine dihydrochloride in cancer immunotherapy. Authors AM, RF and FBT have received honoraria and/or travel grants from the study sponsor. The remaining authors declare no conflict of interest.